1U. Grouven,L. G. Hemkens,R. Bender,P. T. Sawicki.Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues. Reply to Nagel JM, Mansmann U, Wegscheider K et al. [letter] and Simon D [letter][J]. Diabetologia . 2010 (1)
2P. D. Home,P. Lagarenne.Combined randomised controlled trial experience of malignancies in studies using insulin glargine[J]. Diabetologia . 2009 (12)
3Mayer D,Shukla A,Enzmann H.Proliferative effects of insu-lin analogues on mammary epithelial cells. Arch PhysiolBiochem . 2008
4Weinstein D,Si mon M,Yehezkel E,et al.Insulin analoguesdisplay IGF-Ⅰ-like mitogenic and anti-apoptotic activities incultured cancer cells. Diabetes Metabolism Reviews . 2009
5Jonasson J M,Ljung R,Talback M,et al.Insulin glargine useand short-termincidence of malignancies-a population-basedfollow-up study in Sweden. Diabetologia . 2009
6Currie C J,Poole C D,Gale E A.The influence of glucose-lowering therapies on cancer riskintype 2 diabetes. Diabetogia . 2009
7Gale E A.Insulin glargine and cancer:another side to the sto-ry?. The Lancet . 2009
8I Stammberger,A Bube,B Durchfeld-Meyer,H Donaubauer,G Troschau.Evaluation of the carcinogenic potential of insulin glargine (LANTUS) in rats and mice. International Journal of Toxicology . 2002
9Sandhu MS,Dunger DB,Giovannucci EL.Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. Journal of the National Cancer Institute . 2002
10P Kurtzhals,L Schaffer,A Sorensen,et al.Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes . 2000
同被引文献5
1Abraham NS,Hlatky MA,Antman EM,et al.ACCF/ACG/AHA 2010 expert consensus document on the concomitant useof proton pump inhibitors and thienopyridines:a focused updateof the ACCF/ACG/AHA 2008 expert consensus document onreducing the gastrointestinal risks of antiplatelet therapy andNSAID use[].Journal of the American College of Cardiology.2010
2DL Campbell-Scherer,LA Green.ACC/AHA guideline update for the management of ST-segment elevation myocardial infarction[].American Family Physician.2009
3Van de Werf F,Bax J,Betriu A,et al.Management of acute myocardial infarction in patients presenting with persis-tent ST-segment elevation:the task force on the manage-ment of ST-Segment elevation acute myocardial infarc-tion of the european society of cardiology[].European Heart Journal.2008
